JP2023520977A5 - - Google Patents
Info
- Publication number
- JP2023520977A5 JP2023520977A5 JP2022551673A JP2022551673A JP2023520977A5 JP 2023520977 A5 JP2023520977 A5 JP 2023520977A5 JP 2022551673 A JP2022551673 A JP 2022551673A JP 2022551673 A JP2022551673 A JP 2022551673A JP 2023520977 A5 JP2023520977 A5 JP 2023520977A5
- Authority
- JP
- Japan
- Prior art keywords
- cxcr4
- patent document
- epi
- international publication
- international
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025138725A JP2025186263A (ja) | 2020-02-27 | 2025-08-22 | Ｅｐｉ－ｘ４系ペプチドおよびその誘導体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20159879.4A EP3872084A1 (en) | 2020-02-27 | 2020-02-27 | Epi-x4 based peptides and derivatives thereof |
| EP20159879.4 | 2020-02-27 | ||
| PCT/EP2021/054794 WO2021170782A2 (en) | 2020-02-27 | 2021-02-26 | Epi-x4 based peptides and derivatives thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025138725A Division JP2025186263A (ja) | 2020-02-27 | 2025-08-22 | Ｅｐｉ－ｘ４系ペプチドおよびその誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023520977A JP2023520977A (ja) | 2023-05-23 |
| JP2023520977A5 true JP2023520977A5 (enExample) | 2024-03-01 |
| JP7733664B2 JP7733664B2 (ja) | 2025-09-03 |
Family
ID=69742821
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022551673A Active JP7733664B2 (ja) | 2020-02-27 | 2021-02-26 | Ｅｐｉ－ｘ４系ペプチドおよびその誘導体 |
| JP2025138725A Pending JP2025186263A (ja) | 2020-02-27 | 2025-08-22 | Ｅｐｉ－ｘ４系ペプチドおよびその誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025138725A Pending JP2025186263A (ja) | 2020-02-27 | 2025-08-22 | Ｅｐｉ－ｘ４系ペプチドおよびその誘導体 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20230131339A1 (enExample) |
| EP (2) | EP3872084A1 (enExample) |
| JP (2) | JP7733664B2 (enExample) |
| WO (1) | WO2021170782A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202216558D0 (en) * | 2022-11-07 | 2022-12-21 | Univ Liverpool | New antibacterial products |
| EP4483892A1 (en) * | 2023-06-29 | 2025-01-01 | Pharis Biotec GmbH | Composition comprising lekti polypeptides for the treatment of disorders |
| WO2025114560A1 (en) * | 2023-12-01 | 2025-06-05 | Pharis Biotec Gmbh | Alb408-423 peptides for use in the treatment of cancer in combination with radiotherapy |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102007030904A1 (de) | 2007-07-03 | 2009-02-05 | Pharis Biotec Gmbh | Humanes zirkulierendes antivirales Albumin-Fragment (ALB-408) und seine Verwendung |
| SMT201800589T1 (it) | 2013-06-12 | 2019-01-11 | Pharis Biotec Gmbh | Peptidi con attivita' antagoniste contro cxcr4 naturale |
| CA3072009A1 (en) * | 2017-09-08 | 2019-03-14 | Neopep Pharma Gmbh & Co. Kg | Crcx4 inhibitor peptides for the treatment of diseases |
| CN113286806A (zh) * | 2018-11-09 | 2021-08-20 | 尼欧派普制药有限两合公司 | 治疗压力、免疫反应和中风综合征的多肽 |
-
2020
- 2020-02-27 EP EP20159879.4A patent/EP3872084A1/en not_active Withdrawn
-
2021
- 2021-02-26 WO PCT/EP2021/054794 patent/WO2021170782A2/en not_active Ceased
- 2021-02-26 JP JP2022551673A patent/JP7733664B2/ja active Active
- 2021-02-26 US US17/801,684 patent/US20230131339A1/en active Pending
- 2021-02-26 EP EP21707688.4A patent/EP4110790A2/en active Pending
-
2025
- 2025-08-22 JP JP2025138725A patent/JP2025186263A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023520977A5 (enExample) | ||
| JP2022502371A5 (enExample) | ||
| JP7128246B2 (ja) | 抗炎症活性を有するペプチド、及びそれを含む組成物 | |
| JP2023544834A5 (enExample) | ||
| JP2018509935A5 (enExample) | ||
| JP2020537644A5 (enExample) | ||
| JP2020519643A5 (enExample) | ||
| US20140141488A1 (en) | Sequence of 55 new found proteins and their application | |
| JP2011502964A5 (enExample) | ||
| JP2016000731A5 (enExample) | ||
| JP2006149365A5 (enExample) | ||
| JP2019516665A5 (enExample) | ||
| JP2015212284A5 (enExample) | ||
| JP2022534782A5 (enExample) | ||
| JP2023554379A5 (enExample) | ||
| JP2013516427A5 (enExample) | ||
| JP2020517260A5 (enExample) | ||
| JPWO2020059847A5 (enExample) | ||
| JP2024520234A5 (enExample) | ||
| JP2020535811A5 (enExample) | ||
| JPWO2020027010A5 (enExample) | ||
| DK1305334T3 (da) | Urocortinproteiner og anvendelser deraf | |
| JP2018516247A5 (enExample) | ||
| JP2019038772A5 (enExample) | ||
| JP2023521031A5 (enExample) |